Skip to content

Dimethyl Fumarate

Also known as Tecfidera (us), Xemus (india)

Autoimmune & Inflammation
Save $4,710/mo
53× cheaper

An oral disease-modifying therapy for relapsing multiple sclerosis.

United States
$4,800
per month
India
$90
per month
You save
$4,710
98% cheaper in India
75.5K US scripts/yr$355.4M potential annual savings$362.2M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC6H8O4

SMILES: COC(=O)/C=C/C(=O)OC

Compare the price
US price$4,800per month
India price$90per month
You save$4,71098% less

Based on 60 capsules per month. US $80.00 vs India $1.50 per capsule.

Total over 1 periodSave $4,710$4,800$90
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$28,260
Estimated travel cost
− $2,300
Net savings after travel
$25,960

Even after travel, you could come out ahead by about $25,960.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Dimethyl Fumarate is filled about 75.5K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$362.2M
If sourced from India
$6.8M
Potential annual savings
$355.4M
98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.